基础医学与临床 ›› 2018, Vol. 38 ›› Issue (6): 815-820.

• 研究论文 • 上一篇    下一篇

原核表达及一步法制备可溶性白喉毒素突变体CRM197

高宇辉,邓唯唯   

  1. 中国医学科学院基础医学研究所 北京协和医学院基础学院
  • 收稿日期:2018-03-30 修回日期:2018-04-23 出版日期:2018-06-05 发布日期:2018-05-25
  • 通讯作者: 高宇辉 E-mail:gaoyuhui@ibms.pumc.edu.cn
  • 基金资助:
    中国医学科学院医学与健康科技创新工程

Prokaryotic expression and one-step purification of soluble diphtheria toxin variant CRM197

  • Received:2018-03-30 Revised:2018-04-23 Online:2018-06-05 Published:2018-05-25
  • Contact: Yh-Hui GAO E-mail:gaoyuhui@ibms.pumc.edu.cn
  • Supported by:
    CAMS Innovation Fund for Medical Sciences(CIFMS)

摘要: 目的 构建一种新型的重组蛋白大肠杆菌胞内自动切割表达系统,表达可溶性的CRM197重组蛋白,实现一步法纯化。方法 将CRM197编码序列与硫氧还蛋白(Trx)序列以融合表达方式克隆于原核表达载体pET-32a(+)载体上,Trx与CRM197之间加入HRV3C(人鼻病毒3C)蛋白酶识别区序列和组氨酸纯化标签编码序列,HRV3C蛋白酶基因克隆于原核表达质粒pGArasd,共同转染大肠杆菌Origami B (DE3),15℃温和诱导,并使用Ni-NTA基质亲和纯化CRM197重组蛋白。结果 CRM197融合蛋白表达后,随即被伴随表达的HRV3C蛋白酶水解释放出游离的带His标签的CRM197重组蛋白,经过一步法亲和纯化,得到纯度约95%的CRM197样品。与DNA共同孵育,显示所获CRM197重组蛋白具有脱氧核糖核酸酶活性。结论 通过构建新型的双质粒自动切割原核表达系统,本研究简化了在大肠杆菌表达纯化可溶性CRM197重组蛋白的工艺,降低了制备成本。

关键词: 白喉毒素突变体, 可溶性表达, 自动切割, 纯化

Abstract: Objective To construct a novel prokaryotic expression system, in which cross-reacting material 197 (CRM197) can be expressed as soluble form in Escherichia coli (E. coli) cytoplasm and purified by simply one-step Ni-NTA affinity purification. Methods The CRM197 coding sequence were cloned into the prokaryotic expression vector pET-32a(+) as an fusion protein with Trx tag,and the HRV3C (human rhinovirus 3C) protease recognition sequence and 6 histidine sequence were added to the N-terminal of CRM197. HRV3C protease gene was cloned into another prokaryotic expression plasmid pGArasd. Both plasmids were co-transfected into E. coli Origami B (DE3) and induced mildly at 15℃. CRM197 recombinant protein was purified by Ni-NTA affinity matrix. Results The free soluble His-tagged CRM197 protein was released by cleavage of the accompanying expressed HRV3C protease after the CRM197 fusion protein was expressed. After one-step affinity purification recombinant CRM197 protein with a purity of almost 95% was obtained. Outcoming of the final preparation incubated with DNA indicated the purified CRM197 recombinant protein has deoxyribonuclease activity. Conclusions By constructing a novel double-plasmid auto-cleavage prokaryotic expression system in this study,the production process of obtain soluble CRM197 recombinant protein in E. coli has been simplified,with expression and purification efficiency improved and the production cost reduced.

Key words: diphtheria toxin mutant, soluble expression, autocleavage, purification

中图分类号: